You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 144 No. 9, September 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Research Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dermatology
 •Dermatologic Disorders
 •Psoriasis
 •Dermatologic Procedures
 •Phototherapy
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Home Narrowband UV-B Phototherapy in Combination With Low-Dose Acitretin in Patients With Moderate to Severe Psoriasis

Christopher B. Yelverton, MD, MBA; Brad A. Yentzer, MD; Adele Clark, PA-C; Daniel J. Pearce, MD; Rajesh Balkrishnan, PhD; Fabian T. Camacho, MS; Ann Boles, RN, CCRC; Alan B. Fleischer Jr, MD; Steven R. Feldman, MD, PhD

Arch Dermatol. 2008;144(9):1224-1225.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Acitretin plus UV-B phototherapy is a highly effective and relatively safe treatment for psoriasis, limited by the inconvenience and cost of office-based treatment.1 Home phototherapy offers greater convenience, but the safety and efficacy of its use outside the physician's office has not been well studied.2 The purpose of this study is to provide a preliminary assessment of home-based narrowband UV-B phototherapy plus low-dose acitretin for moderate to severe psoriasis.

Methods

After institutional review board approval, 27 adult subjects were recruited. All subjects had moderate to severe plaque-type psoriasis (Psoriasis Area Severity Index [PASI] ≥12) and no child-bearing potential or contraindications for acitretin or phototherapy. A 4-week washout was required for any systemic psoriasis therapy, . . . [Full Text of this Article]


Results

Comment

AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis: pragmatic multicentre randomised controlled non-inferiority trial (PLUTO study)
Koek et al.
BMJ 2009;338:b1542-b1542.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.